Angewandte Chemie International Edition
© WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
January 25, 2006
New Members of the International Advisory Board (1)...
Biochemistry: Lia Addadi
L. Addadi studied organic chemistry at the Università degli Studi di Padova (Italy) and obtained her PhD in 1979 from the Weizmann Institute in Rehovot (Israel) under the guidance of M. Lahav. She then worked as a postdoctoral researcher in the group of J. R. Knowles at Harvard University (USA) before returning in 1988 to the Weizmann Institute as a professor. The research interests of her group lie in biomineralization and the interactions of cells, proteins, and antibodies with crystals. Addadi serves as a member of the advisory board for ChemBioChem, and recently discussed therein the concept of the spatial and temporal sequence of events during cell adhesion, and reported on a new family of proteins rich in aspartic acid from the prismatic shell matrix of the bivalve Atrina rigida.
Novel Materials: Chun-Li Bai
C.-L. Bai obtained his PhD in 1985 from the Institute of Chemistry of the Chinese Academy of Sciences in Beijing. After a postdoctoral stay at the California Institute of Technology in Pasadena (USA), he returned to China in 1987. During 1991–92, he was a visiting professor in Japan at the University of Tohoku in Sendai. Bai is interested in the development of new scanning probe microscopes for surface analysis. He recently reported in Angewandte Chemie on the mass production and high photocatalytic activity of ZnS nanoporous nanoparticles, and in ChemPhysChem on the effect of polarity on co-adsorbed molecular nanostructures of substituted phthalocyanine and thiol molecules. Bai is Executive Vice-President of the Chinese Academy of Sciences and President of the Chinese Chemical Society.
Medicinal Chemistry: Scott Biller
S. Biller is Head of Global Discovery Chemistry at the Novartis Institutes for Biomedical Research and is responsible for projects in combinatorial, medicinal, and computational chemistry across the Novartis sites in Basel, Cambridge (MA), Vienna, and Horsham (UK). He carried out undergraduate research with K. B. Sharpless (Massachusetts Institute of Technology, USA), completed his PhD in 1982 with D. Evans at the California Institute of Technology, and then worked as a postdoctoral fellow with G. Stork at Columbia University in New York (1982–83). During his career he has held many key positions in the field of drug development, including Vice-President of Pharmaceutical Candidate Optimization at Bristol–Myers Squibb (BMS), Head of Discovery Chemistry at BMS, and Executive Director of Metabolic Diseases Chemistry.
 a) J.-S. Hu, L.-L. Ren, Y.-G. Guo, H.-P. Liang, A.-M. Cao, L.-J. Wan, C.-L. Bai, Angew. Chem. 2005, 117, 1295; Angew. Chem. Int. Ed. 2005, 44, 1269, b) Z.-Y- Yang, S.-B. Lei, L.-H. Gan, L.-J. Wan, C. Wang, C.-L. Bai, ChemPhysChem 2005, 6, 65.